Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EPOBY | CRBJY |
|---|---|---|
| Price | $21.48 | $36.46 |
| Change today | ▲ 0.00% | ▲ 0.00% |
| Market cap | $25.98B | $26.00B |
| Return, 3 months | -6.6% | -9.7% |
| Return, year to date | +17.5% | +6.4% |
| Return, 1 year | +13.9% | -2.5% |
| P/E (TTM) | 27.5 | 7.8 |
| P/B | 0.6 | 0.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.89% | 4.69% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 35 | 29 |
| 30-day volatility | 16.0% | 61.3% |
| Max drawdown, 1 year | -12.0% | -22.6% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
